Glycolink AB

Active
559266-7918Limited company (AB)Registered 2020STOCKHOLM

Key figures

1 165 388 kr
Revenue 2025
+140,2%
Average annual growth 2021–2025
0500 k1 m1,5 m20212022202320242025

Key figures

2025

Summary: Glycolink AB

What kind of company is it?

Glycolink AB (org. no. 559266-7918) is a limited company (AB). The company was registered in 2020 and has existed for 6 years. Registered seat: Stockholm. Industry according to Statistics Sweden: research and experimental development on biotechnology (SNI 72101).

How is the company doing financially?

Net sales in financial year 2025 were 1 165 388 kr. From 2021 to 2025, net sales grew by an average of 140 % per year. This is the highest net sales among the reported years (2021–2025). Financial year 2025 ended with a loss of 1 481 073 kr. The company was profitable in 3 of the 5 reported financial years. Employees in financial year 2025: 2 (previous year: 1). Net sales per employee were 582 694 kr. At the end of financial year 2025, total assets were 3 731 651 kr and equity 3 495 454 kr (equity ratio 93,7 %).

Where does the data come from and how up to date is it?

Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by 5 people. Data as of 2026-11-16. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.

Summary of annual reports2021–2025
20212022202320242025
Sales revenue35 0000001 165 388
Profit for the reporting year7 20093498 852−877 759−1 481 073
Retained earnings of previous periods—————
Total assets76 461525 385464 9151 873 9293 731 651
Total liabilities34 171362 16152 839248 096236 197
Total equity42 290163 224412 0761 625 8333 495 454
Employees——112
Proposed dividend———00

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.